Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study

BACKGROUND: Because the major event in COVID-19 is the release of pre- and inflammatory cytokines, finding a reliable therapeutic strategy to inhibit this release, help patients manage organ damage and avoid ICU admission or severe disease progression is of paramount importance. Photobiomodulation (...

Descripción completa

Detalles Bibliográficos
Autores principales: Marashian, Seyed Mehran, Hashemian, Mohammadreza, Pourabdollah, Mihan, Nasseri, Mansour, Mahmoudian, Saeed, Reinhart, Florian, Eslaminejad, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304695/
https://www.ncbi.nlm.nih.gov/pubmed/35874678
http://dx.doi.org/10.3389/fimmu.2022.929837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304695/
https://www.ncbi.nlm.nih.gov/pubmed/35874678
http://dx.doi.org/10.3389/fimmu.2022.929837

Ejemplares similares